2-[8-bromo-2-(3-chlorophenyl)-6-methylimidazo[1,2-a]pyridin-7-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid
C20H20BrClN2O3 — CID 118326910
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[8-bromo-2-(3-chlorophenyl)-6-methylimidazo[1,2-a]pyridin-7-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid
2-[8-bromo-2-(3-chlorophenyl)-6-methylimidazo[1,2-a]pyridin-7-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid (PubChem CID 118326910) has the molecular formula C20H20BrClN2O3 and a molecular weight of 451.75 g/mol. Its IUPAC name is 2-[8-bromo-2-(3-chlorophenyl)-6-methylimidazo[1,2-a]pyridin-7-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid.
Molecular Properties
| Compound Name | 2-[8-bromo-2-(3-chlorophenyl)-6-methylimidazo[1,2-a]pyridin-7-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid |
|---|---|
| PubChem CID | 118326910 |
| Molecular Formula | C20H20BrClN2O3 |
| Molecular Weight | 451.75 g/mol |
| Exact Mass | 450.03 |
| IUPAC Name | 2-[8-bromo-2-(3-chlorophenyl)-6-methylimidazo[1,2-a]pyridin-7-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid |
| SMILES | Cc1cn2cc(-c3cccc(Cl)c3)nc2c(Br)c1C(OC(C)(C)C)C(=O)O |
| InChI | InChI=1S/C20H20BrClN2O3/c1-11-9-24-10-14(12-6-5-7-13(22)8-12)23-18(24)16(21)15(11)17(19(25)26)27-20(2,3)4/h5-10,17H,1-4H3,(H,25,26) |
| InChIKey | MYMZXMVVEQGLFC-UHFFFAOYSA-N |
| XLogP | 5.67 |
| TPSA | 63.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 451.75 |
| LogP ≤ 5 | 5.67 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118326910 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.